Can Cabozantinib be purchased in China?

The mechanism of action of Cabozantinib (Cabozantinib) is to interfere with the proliferation, angiogenesis and metastasis of tumor cells by inhibiting the activity of multiple receptor kinases. It mainly targets key receptor kinases such as vascular endothelial growth factor receptor (VEGFR), hepatocyte growth factor receptor (MET), platelet-derived growth factor receptor (PDGFR).

For patients with advanced or metastatic renal cell carcinoma, cabozantinib is an important treatment that can prolong survival and relieve symptoms. Cabozantinib is also an effective treatment option for patients with thyroid cancer, particularly those with locally advanced or metastatic disease that has not responded to radioactive iodine therapy.

The side effects of cabozantinib may include high blood pressure, diarrhea, fatigue, hand-foot syndrome, etc. Therefore, it is necessary to closely monitor the patient's condition and adverse reactions when using it, and follow the doctor's guidance and recommendations.

Please note that drug information may change over time and it is recommended that you follow the latest medical information and physician advice when using it.

Cabozantinib is not currently on the market in China and is therefore not included in medical insurance because it requires approval from the National Medical Products Administration. Therefore, patients cannot purchase it domestically and need to purchase it through overseas channels. There are original and generic cabozantinib drugs abroad. The original drugs are mainly Japanese original drugs, Turkish original drugs and European original drugs. The price is relatively high, ranging from 35,000 to 46,000 yuan. Foreign generic drugs are mainly Lao generic drugs and Bangladeshi generic drugs, with prices ranging from 1,300 to 2,700 yuan. The price is much cheaper than original drugs and is more suitable for the needs of patients in ordinary families. The ingredients of original drugs and generic drugs are basically the same.